Article Name Predictive Diagnostics
Medical humanities education expanded to train future-ready doctors to be agile
11th September, 2023
Acquisition will bring together two leaders in different aspects of diabetes care
07th September, 2023
IVIS® Spectrum 2 and IVIS SpectrumCT 2imaging systems — new flagship platforms setting the standard in high-throughput performance and versatility
06th September, 2023
OMRON Healthcare Manufacturing India (a subsidiary of OMRON Healthcare Corporation Japan) has begun the construction of its new plant in Chennai in May 2023. Being built with an investment of Rs 128 crore, this state-of-the-art facility will mark the company’s debut in the healthcare manufacturing space in India and will further strengthen its presence in the home healthcare device industry in the country as well as its global network of production facilities with locations in Japan, China, Vietnam, Italy and Brazil. In conversation with BioSpectrum Asia & MedTech Spectrum, Tetsuya Yamada, Managing Director, OMRON Healthcare India talks about the company’s growth plans in Asia.
04th September, 2023
Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale
30th August, 2023
Healthium Medtech, a global leader in medical technology solutions, announced that the company has launched TRUMASTM, a range of sutures meticulously designed to address challenges faced during suturing in minimal access surgeries. As India celebrates its 77th year of Independence, Healthium reaffirms its commitment to innovation in the Indian medtech landscape by introducing such a path-breaking solution designed to revolutionize suturing during minimal access procedures.
30th August, 2023
The incubator aims to advance healthcare innovations by fostering a thriving ecosystem for biomedtech startups
28th August, 2023
Enabling the state of Uttar Pradesh with a modern high-tech lab, aiming to transform patient care
23rd August, 2023
An aero-elastic sensor that revolutionises the way pressure is detected
22nd August, 2023
First microarray-based solution in Singapore to enable multi-gene panel testing for pharmacogenomics and disease risk assessment
16th August, 2023
Company Adds Key Products to its Comprehensive Cervical Spine Portfolio
16th August, 2023
GASTROClear is the first miRNA blood test and the first gastric cancer molecular test globally to receive FDA Breakthrough Device Designation
14th August, 2023
To provide crucial information that could ultimately be used to improve treatments
07th August, 2023
Announces AI-powered visual-to-text transformation pilot testing for dental X-rays, with Kindlehouse Dentistry partnership
07th August, 2023
Yashoda Medicity, the upcoming healthcare facility by Yashoda Foundations in Indirapuram, is collaborating with Draeger India, a renowned global medical and safety technology solutions provider. Yashoda Medicity is the new addition to the renowned healthcare institution Yashoda Super Speciality Hospital, well acknowledged for its exceptional patient care and facilities. Together, Yashoda Medicity and Dräger are embarking on a groundbreaking initiative to establish one of the largest modular Intensive Care Unit (ICU) setup in South Asia. The focus of this project is to prioritize infection prevention control, patient and staff safety, and enhanced hospital efficiency, while ensuring adaptability to respond to the ever-evolving needs of the hospital.
03rd August, 2023
JelloX Biotech, a Taiwanese startup, is at the forefront of revolutionising cancer pathology by utilising 3D digital imaging and Artificial Intelligence (AI) technology. Its 3D imaging technology demonstrates potential beyond the field of oncology. In a groundbreaking paper published in February 2023, Dr Lin-Shien Fu and colleagues from Taiwan's Taichung Veterans General Hospital showcased the innovative application of their 3D pathology in analysing kidney inflammation caused by lupus nephritis. Dr Yen-Yin Lin, CEO of JelloX Biotech, highlights this new era in digital pathology, unveils the company's growth plans, strategic partnerships, and significant developments.
03rd August, 2023
Biomedicine is a top priority for Taiwan, with the government aiming to position the country as the leading hub for biomedical research and development in the Asia-Pacific region. By 2025, Taiwan aims to create 20 new medicines, introduce 80 high-value medical devices to the market, and elevate the biomedicine industry into a trillion-NT-dollar (approximately $32 billion) sector. The government has taken various initiatives, established biomedicines clusters and tweaked policies to achieve this goal. Has the effort paid off? How far has the country come to achieve its goals? Let’s find out.
03rd August, 2023
To drive Strand's clinical genomic tests and the newly launched Genomic Health Insights programme to make sequencing accessible to all
02nd August, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer